Inclusion Criteria:  Pediatric patients with Congenital or Acquired Heart Disease Requiring Chronic Anticoagulation for Thromboembolism Prevention Previously participated in the CV185-362 study and was on apixaban for 1 year or until treatment was no longer required  Exclusion Criteria:  Weight less than 5 kg or greater than 35 kg  Other inclusion/exclusion criteria apply